News & Analysis: Vaccine access and delivery

Decolonising the coronavirus vaccine

“Since less than 1% of vaccines consumed in Africa are manufactured on the continent, regional efforts to develop vaccine manufacturing capacity such as those led by the Africa Centre for Disease Control and Prevention, as well as the Alliance of African Research Universities, must be supported. These efforts collectively advance delinking and move us closer toward the re-ordering of systems of power.”

via Mail & Guardian

Crafting a framework for Africa’s COVID-19 vaccine access

“Drastic measures to contain the spread of COVID-19, such as strict lockdowns, are not sustainable on many parts of the African continent because of crowded living conditions and the need to keep economies afloat. That’s why an effective vaccine is one of the best chances African countries have to return to normalcy, experts said this week.”

via Devex

Coronavirus: Africa leads vaccine quest with trials in Johannesburg

“COVID-19 has hit South Africa harder than any other country on the continent. That makes it a good place to test the vaccine candidate, as volunteers are likely to come into contact with the virus relatively quickly. The study will follow up to 2,000 volunteers over 12 months.”

via The Africa Report

Nine things to know about Africa’s first COVID-19 vaccine trial

“South Africa might be taking a small step towards eradicating COVID-19 when the country enrolls its first participant in a COVID-19 vaccine trial — the continent’s first. A vaccine developed by Oxford University will be tested on 2 000 trial volunteers… Wondering why we’re doing a trial in the first place? Or how and when we’ll know if the vaccine being tested has been successful? We answer nine questions you may have.”

via Bhekisisa Centre for Health Journalism

COVID-19: How can China help African countries have a stake in the race for a vaccine?

“While China’s pharma industry has had a much smaller global footprint than many other countries such as the UK, U.S. and even India, the experience of the Comoros, an African island nation, and its efforts against malaria with Chinese support, act as an interesting case study.”

via Development Reimagined

More than 140 world leaders: ‘Uniting behind a people’s vaccine’

“Governments and international partners must unite around a global guarantee which ensures that, when a safe and effective vaccine is developed, it is produced rapidly at scale and made available for all people, in all countries, free of charge.”


How to Make Sure the Market Delivers a COVID-19 Vaccine

“Every country faces the same fundamental challenge in the face of the COVID-19 pandemic. Their economies and societies cannot fully return to ‘normal’ until we have a safe and effective vaccine. And achieving that goal quickly is not easy. We see four big problems.”

via Center for Global Development

Global solidarity collapses over access to coronavirus testing kits and vaccines, says Africa CDC director

“Rather than a lack of funds or political will, Africa’s shortfall is triggered by richer nations outcompeting the developing world for critical equipment, says John Nkengasong, director of the Africa Centres for Disease Control and Prevention (Africa CDC).”

via African Business Magazine

African scientists must make sure they are part of the search for a coronavirus vaccine

“Finding a vaccine for COVID-19 is a worldwide medical emergency, necessary to prevent the death of millions of people. Should Africa participate in a global clinical trial? Absolutely. To refuse inclusion would prevent Africa’s researchers from being significant players in the universal fight against the virus.”

via Quartz Africa